ArticleFrontiers in pharmacology2024

The first-in-class pro-apoptotic peptide PEP-010 is effective in monotherapy and in combination with paclitaxel on resistant ovarian adenocarcinoma cell models.

Aline Lacroix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.